Autoimmune and Inflammatory Immunomodulators Market Report

Global and Region Autoimmune and Inflammatory Immunomodulators Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：143
  • REPORT CODE：GMM993229
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Autoimmune and Inflammatory Immunomodulators market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Autoimmune and Inflammatory Immunomodulatorsmarket, defines the market attractiveness level of Autoimmune and Inflammatory Immunomodulators market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Autoimmune and Inflammatory Immunomodulators industry, describes the types of Autoimmune and Inflammatory Immunomodulators market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autoimmune and Inflammatory Immunomodulators market and the development prospects and opportunities of Autoimmune and Inflammatory Immunomodulators industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autoimmune and Inflammatory Immunomodulators market in Chapter 13.

    By Player:

    • Biogen Idec

    • Bristol-Myers Squibb

    • F Hoffmann-La Roche

    • AstraZeneca

    • AbbVie

    • Amgen

    • Avaxia Biologics

    • Eli Lilly

    • Boehringer Ingelheim

    • Enlivex Therapeutics

    • Pfizer

    • Gilead Sciences

    • Johnson & Johnson

    By Type:

    • Biologics

    • Small molecules

    By End-User:

    • Rheumatoid arthritis

    • IBD

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Autoimmune and Inflammatory Immunomodulators Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Autoimmune and Inflammatory Immunomodulators Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Autoimmune and Inflammatory Immunomodulators Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Autoimmune and Inflammatory Immunomodulators Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Autoimmune and Inflammatory Immunomodulators Market Analysis and Outlook to 2022

    • 7.1 Global Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.2 United States Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.3 Europe Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.4 China Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.5 Japan Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.6 India Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    • 7.7 South Korea Autoimmune and Inflammatory Immunomodulators Consumption (2017-2022)

    8 Region and Country-wise Autoimmune and Inflammatory Immunomodulators Market Analysis and Outlook to 2028

    • 8.1 Global Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.2 United States Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.3 Europe Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.4 China Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.5 Japan Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.6 India Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    • 8.7 South Korea Autoimmune and Inflammatory Immunomodulators Consumption Forecast (2022-2028)

    9 Global Autoimmune and Inflammatory Immunomodulators Market Outlook by Types and Applications to 2022

    • 9.1 Global Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Biologics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Small molecules Consumption and Growth Rate (2017-2022)

    • 9.2 Global Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Rheumatoid arthritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global IBD Consumption and Growth Rate (2017-2022)

    10 Global Autoimmune and Inflammatory Immunomodulators Market Outlook by Types and Applications to 2028

    • 10.1 Global Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Biologics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Small molecules Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Rheumatoid arthritis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global IBD Consumption Forecast and Growth Rate (2022-2028)

    11 Global Autoimmune and Inflammatory Immunomodulators Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Autoimmune and Inflammatory Immunomodulators Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Autoimmune and Inflammatory Immunomodulators Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Autoimmune and Inflammatory Immunomodulators Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Autoimmune and Inflammatory Immunomodulators Market Competitive Analysis

    • 14.1 Biogen Idec

      • 14.1.1 Biogen Idec Company Details

      • 14.1.2 Biogen Idec Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen Idec Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.2 Bristol-Myers Squibb

      • 14.2.1 Bristol-Myers Squibb Company Details

      • 14.2.2 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.3 F Hoffmann-La Roche

      • 14.3.1 F Hoffmann-La Roche Company Details

      • 14.3.2 F Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 F Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.4 AstraZeneca

      • 14.4.1 AstraZeneca Company Details

      • 14.4.2 AstraZeneca Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.5 AbbVie

      • 14.5.1 AbbVie Company Details

      • 14.5.2 AbbVie Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AbbVie Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.6 Amgen

      • 14.6.1 Amgen Company Details

      • 14.6.2 Amgen Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Amgen Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.7 Avaxia Biologics

      • 14.7.1 Avaxia Biologics Company Details

      • 14.7.2 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.9 Boehringer Ingelheim

      • 14.9.1 Boehringer Ingelheim Company Details

      • 14.9.2 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.10 Enlivex Therapeutics

      • 14.10.1 Enlivex Therapeutics Company Details

      • 14.10.2 Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.12 Gilead Sciences

      • 14.12.1 Gilead Sciences Company Details

      • 14.12.2 Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Gilead Sciences Autoimmune and Inflammatory Immunomodulators Product and Service

    • 14.13 Johnson & Johnson

      • 14.13.1 Johnson & Johnson Company Details

      • 14.13.2 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Autoimmune and Inflammatory Immunomodulators

    • Figure Autoimmune and Inflammatory Immunomodulators Picture

    • Table Global Autoimmune and Inflammatory Immunomodulators Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autoimmune and Inflammatory Immunomodulators Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autoimmune and Inflammatory Immunomodulators Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Autoimmune and Inflammatory Immunomodulators Consumption by Country (2017-2022)

    • Figure United States Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Table Europe Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure China Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure Japan Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure India Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure South Korea Autoimmune and Inflammatory Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune and Inflammatory Immunomodulators Consumption Forecast by Country (2022-2028)

    • Figure United States Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Autoimmune and Inflammatory Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Small molecules Consumption and Growth Rate (2017-2022)

    • Figure Global Rheumatoid arthritis Consumption and Growth Rate (2017-2022)

    • Figure Global IBD Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small molecules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheumatoid arthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBD Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Autoimmune and Inflammatory Immunomodulators Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Autoimmune and Inflammatory Immunomodulators Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Avaxia Biologics (Foundation Year, Company Profile and etc.)

    • Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Enlivex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Autoimmune and Inflammatory Immunomodulators Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US